Wednesday, dermatology company DUSA Pharmaceuticals, Inc. (DUSA) reported a narrower net loss for the fourth quarter, despite lower revenues.
Net loss for the quarter narrowed to $2 million or $0.08 per share from $7 million or $0.31 per share in the year-ago quarter.
Non-GAAP net loss widened $1.4 million or $0.06 per share from $0.5 million or $0.02 per share in the same period last year.
Non-GAAP results for the recent quarter excluded stock based compensation of about $600 thousands, while last year's non-GAAP excluded impairment of goodwill of $6.8 million and a gain on change in fair value of warrants of $687 thousands.
Total product revenues for the quarter declined to $7.8 million from $8.3 million in the same period last year.
PDT revenues for the quarter totaled $7.5 million, an increase of $1.3 million over the same period last year. The company attributed the increase in PDT revenues to a $1.1 million increase in Kerastick revenues, driven by 29% domestic revenue growth. Overall Kerastick sales volumes increased to 62,260 units, up from 60,580 units in the comparable prior year period.
Non-PDT revenues totaled $0.3 million, compared with $2.2 million in the same period last year. The company said non-PDT revenues were adversely impacted by the absence of sales of Nicomide during the fourth quarter of 2008.
For the twelve-month period, net loss, on a GAAP basis, narrowed to $6.3 million or $0.26 per share from $14.7 million or $0.73 per share in 2007. Non-GAAP net loss narrowed to $3.9 million or $0.16 per n share in 2008 from $7.1 million or $0.35 per share in 2007.
Total product revenues were $29.5 million, as compared to $27.7 million in 2007. PDT revenues for the twelve-month period totaled $23.9 million, an increase of $5.7 million over the comparable 2007 period.
Robert Doman, President and chief executive officer said, we significantly reduced our annual cash burn, excluding non-recurring items, from $8.3 million in 2007 to just $2.4 million in 2008."
DUSA closed Tuesday's regular trading session at $1.25.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.